CFAES scientists Linda Saif and Anastasia Vlasova, both of the Food Animal Health Research Program, will be part of a new Ohio State center that will study the long-term, longitudinal impact of COVID-19 on first responders, healthcare workers, and the general population.
The new effort, called the Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID), a new Serological Sciences Center of Excellence, is being funded by a five-year, $10 million grant from the National Cancer Institute in the National Institutes of Health to The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center.
Saif, a Distinguished University Professor and a world-renowned expert on coronaviruses, is one of the center’s four co-principal investigators. Vlasova, who studies emerging animal, human, and zoonotic viruses, will lead one of the center’s six components.
“This is one of the largest grants ever awarded to the College of Medicine,” said Peter Mohler, chief scientific officer for the Wexner Medical Center and vice dean for research for the College of Medicine.
Photo by Ken Chamberlain, CFAES.